Myeloproliferative Neoplastic Diseases Observatory From Brest
Observatoire Brestois Des Néoplasies Myéloprolifératives
University Hospital, Brest
1,000 participants
Sep 1, 2015
OBSERVATIONAL
Conditions
Summary
All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study. Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis. This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).
Eligibility
Inclusion Criteria2
- Patients with essentiel thrombocythemia, polycythemia vera or primary myelofibrosis
- Signature of the non-opposition consent form
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02897297